Pouliot, Frédéric, et al. “Trajectory Timelines and Treatment Efficacy of 177Lu-PSMA-617 Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: Real-World Data from 50 Consecutive Cases Treated in a Single Canadian Center”. Canadian Urological Association Journal, vol. 20, no. 6, Feb. 2026, doi:10.5489/cuaj.9398.